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Objective: To evaluate the performance of Sysmex UF1000i (Sysmex, Kobe, Japan) in predicting signiﬁ-
cant bacteriuria on urine culture from urine specimens of women suspected of uncomplicated urinary
tract infection (uUTI).
Materials and methods: We retrospectively reviewed urine samples from 1680 adult women with lower
urinary tract symptoms suggestive of uUTI from urologic clinics for study. Urine analyses were performed
with laser ﬂow cytometry (Sysmex UF1000i). Standard urine cultures were performed. The predictive
validity for signiﬁcant bacteriuria ( 105 CFU/mL) was analyzed with logistic regression. Receiver
operating characteristic (ROC) curve analysis was used to evaluate the best cut-off point for bacteria
count (BACT/mL) to predict signiﬁcant bacteriuria.
Results: A total of 651 specimens met the criteria for analysis. The results indicated that the BACT/mL
(AUC ¼ 0.94) generated through Sysmex UF1000i outperformed nitrite (AUC ¼ 0.70), leukocyte esterase
(AUC ¼ 0.71), and pyuria (AUC ¼ 0.678) in predicting signiﬁcant bacteriuria. The optimal cut-off point for
bacterial count was set at > 357 BACT/mL with sensitivity of 85.61%, speciﬁcity of 88.52%, positive pre-
dictive value of 91.8%, and negative predictive value of 78.73%. Excluding those specimens with < 357
BACT/mL, we may decrease negative urine culture rate by 36.9%, and miss 14.0% of positive cultures.
Conclusion: Laser ﬂow cytometry (Sysmex UF1000i) can help us rapidly identify patients with signiﬁcant
bateriuria in the preanalytical phase urine culture and thus reduce unnecessary use of antibiotics.
Copyright © 2016, Taiwan Urological Association. Published by Elsevier Taiwan LLC. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Urinary tract infection (UTI) is one of the most common bacte-
rial infections at all levels of healthcare.1 The uncomplicated UTI
(uUTI) is deﬁned as infection in patients with normal genitourinary
tract, while the complicated UTI is infection in those with abnormal
genitourinary tract, immunocompromised status, and/or multidrug
resistant bacteria.1 By the age of 32 years, 50% of women would
have had at least one symptomatic UTI.2 The diagnosis of UTI is
made through clinical symptoms and a positive urine culture.1
Urine culture remains the gold standard for diagnosing UTI, by
identifying the causative pathogen with concentration andNo.289, Jianguo Rd., Xindian
Yang).
ociation. Published by Elsevier Tasusceptibility test.1 High percentages of negative culture results,
ranging from 80e98%, have been reported.3 Also, contamination
accounted for 29e32% of positive urine cultures in symptomatic
female outpatients, despite different collection methods.4 Howev-
er, 23% of symptomatic women exhibited negative urine cultures.5
Urine chemical analysis and microscopic testing, including leuko-
cyte esterase, nitrite, pyuria, and bacteriuria, rapidly provide in-
formation in order to make a diagnosis of uUTI. Despite exhibiting
good diagnostic performance for the detection of UTI, their lack of
accuracy and precision are still being debated.
A new advanced automated urine ﬂow cytometer, Sysmex
UF1000i (Sysmex, Kobe, Japan), has recently served as an alterna-
tive to the expensive, time consuming, and labor-intensive urine
culture method.6 Sysmex UF1000i is designed to analyze urine
sediment at a speed of 100 samples per hour and can rapidly
quantify urine particles, including bacteria, white blood cells
(WBCs), red blood cells (RBCs), epithelial cells, and casts. Using aiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
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UF1000i provides a fast, effective, and reliable screening test by
detecting and quantifying bacteria before culture, which obviates
the need for culture and unnecessary antibiotic use. Previous
studies showed good precision and consistency between Sysmex
UF1000i and urine culture and microscopic counting results.6e12
Although large sampling numbers were included, many did not
speciﬁcally note the patients' clinical status or report the incidence
of contaminated urine samples. To address these issues, we per-
formed a retrospective study to compare the performance of the
bacteria count (BACT/mL) generated through laser ﬂow cytometry
(Sysmex UF1000i) with dipstick chemical analysis and pyuria in
predicting bacteriuria in urine specimens from adult women with
uUTI.2. Materials and methods
2.1. Patients and samples
From October 2014 to October 2015, adult women ( 18 years
old) visiting urological clinics with lower urinary tract symptoms
suggestive of uUTI, i.e., urinary frequency, urgency, dysuria, and
hematuria, were enrolled retrospectively. Samples were excluded
from analysis if urine analysis and urine culture were not per-
formed within 24 hours. Patients were also excluded if they were
febrile (body temperature > 38C), pregnant, if they had genito-
urinary tract anomaly, were undergoing immunosuppressive
therapy, recent antibiotic use (within 1 week), chronic kidney dis-
ease under dialysis, chronic urine retention under urethral cathe-
terization, or bladder cancer.
Midstream urine specimens were collected in sterile containers
for urine analysis and culture. The urine specimens were placed in
10 mL urine sediment centrifuge tubes (SY; Shih-Yung Medical In-
struments Co. Ltd, Taipei, Taiwan) and sent for chemical analysis
and laser ﬂow cytometry (Sysmex UF1000i) examination in our
laboratory. Sysmex UF1000i analysis was performed within 30 mi-
nutes of collection. The study was approved by the Institutional
Review Boards at the Taipei Tzu Chi Hospital, Taipei, Taiwan, with
the protocol number 03-XD49-86.2.2. Sysmex UF1000i
In our hospital, the standard urinalysis is done by Sysmex
UF1000i and one chemistry analyzer. That means that ordering
urine examination does not require extra expense. The results of
sediment analysis were presented in units of per mL and also in per
high power ﬁeld (HPF). Most clinicians are not familiar with the
interpretation of the results from this machine; therefore, our
laboratory still provides the universal format familiar to clinicians.
The Sysmex UF1000i is a fully automated ﬂuorescence ﬂow cy-
tometer which utilizes a 635 nm semiconductor diode laser to
quantify bacteria and sediments in two separated analytical chan-
nels without the need to centrifuge urine specimens. In the bac-
terial channel, the urine specimen was mixed at 42

C. A special
diluent, which increases permeability of the bacterial cell wall,
allowed the polymethine ﬂuorescent dye to stain bacterial DNA.
Each bacterial particle, exposed to a 635 nm laser beam, emitted
various degrees of forward scattered light and side ﬂuorescent light
and could be counted to generate the BACT/mL. In the sediment
channel, WBCs, RBCs, yeast-like cells (YLCs), epithelial cells, crys-
tals, casts, spermatozoa, and mucus were analyzed. Particle/mL
could be transformed to the traditional number per high power
ﬁeld (HPF) by multiplying speciﬁc factors. Pyuria was deﬁned as
WBC > 10/HPF.2.3. Urine culture
A standard quantitative urine culture was performed with a 1 mL
inoculation loop onto commercial chromogenic agar medium (CPS
ID3, Biomerieux, Marcy I'Etoile, France). Culture plates were incu-
bated aerobically at 35C for 18e24 hours. Quantiﬁcation (CFU/mL)
was obtained by multiplying the number of colonies on an agar
plate by the dilution factor. Positive cultures were deﬁned as single
bacterial growth  105 CFU/mL. Mixed growth was deﬁned as
growth of two or more bacteria species without a predominant
organism. No subsequent species identiﬁcation was performed for
the category of mixed growth.
2.4. Statistical analysis
Data was expressed as mean ± standard deviation and analyzed
using commercial statistical software (MedCalc Statistical Software
version 16.1, MedCalc, Ostend, Belgium). The predictive validity of
leukocyte esterase, nitrite, pyuria (> 10/HPF) and BACT/mL for sig-
niﬁcant bacteriuria was analyzed by using logistic regression.
Receiver operating characteristic (ROC) curve analysis was used to
evaluate the best cut-off point for bacteriuria with regard to sig-
niﬁcant bacteriuria. A p value < 0.05 was considered statistically
signiﬁcant.
3. Results
3.1. Screening of signiﬁcant bacteriuria
A total of 1680 urine specimens were screened for analysis.
Exclusion criteria included urine culture and urine analysis not
being performed within 24 hours (n ¼ 264), recent antibiotic use
(n ¼ 82), severe gross hematuria and cloudy urine that might cause
carry over effect (n ¼ 166), mixed growth (n ¼ 467), growth of
fungus (n ¼ 8), lactobacillus (n ¼ 33), and Gardnerella vaginalis
(n ¼ 9). Mixed growth was regarded as contamination and cannot
represent the true causative pathogen in the analysis. Patients with
diabetes mellitus are relatively immunocompromised and more
suspected to urinary tract infection. However, in our study, we did
not specify the patients' status of diabetes mellitus. Among 651
urine specimens eligible for analysis, 90 (13.8%) revealed no
growth. Of the specimens with bacterial growth between 103 CFU/
mL and 105 CFU/mL, 84 (54.9%) were gram negative and 69 (45.1%)
were gram positive. For those with bacterial growth  105 CFU/mL,
369 (90.4%) were gram negative and 39 (9.6%) were gram positive.
Bacterial growth  105 CFU/mL was considered as a cut-off for
culture-positive specimens. The identiﬁed organisms are listed in a
decreasing order of prevalence: Escherichia coli (n ¼ 292), Klebsiella
pneumoniae (n ¼ 31), Proteus mirabilis (n ¼ 29), Streptococci
(n¼ 23), Enterococci (n¼ 9), Citrobacter (n¼ 5), Enterobacter (n¼ 5),
Staphyloccoi (n ¼ 4), Corynebacterium (n ¼ 3), Pseudomonas aeru-
ginosa (n ¼ 3), Klebsiella oxytoca (n ¼ 1), Klebsiella ozaenae (n ¼ 1),
Proteus vulgaris (n ¼ 1), and Providencia rettgeri (n ¼ 1).
3.2. ROC curve analysis
ROC curves were used to deﬁne the optimal cut-off point of
BACT/mL for predicting a positive culture (single bacterial
growth  105 CFU/mL). At the cut-off point of > 357 BACT/mL for a
positive culture, maximized sensitivity (85.89%) and speciﬁcity
(88.43%), with positive predictive value of 91.80% and negative
predictive value of 78.73% were obtained (Table 3). Among the 90
specimens with no growth of organisms, only four specimens
exhibited BACT/mL> 357/mL in ﬂowcytometry.Whenmixed growth
specimens were taken into account, positive predictive value
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74.84%. By excluding those specimens with BACT/mL < 357, we
missed 14.0% (57 out of 408 samples) of positive cultures. Whenwe
applied > 106 BACT/mL (Table 3; sensitivity, 95.79%; speciﬁcity,
70.25%) as the screening cut-off, only 4.9% (20 out of 408 samples)
of positive cultures were left undetected. We also evaluated the
performance of the Sysmex UF1000i for detecting cultures with 
103 CFU/mL and  104 CFU/mL bacterial growth, respectively. For
cultures with growth  103 CFU/mL, a cut-off of 118 BACT/mL with
optimal sensitivity (77.9%) and speciﬁcity (85.6%) is shown in
Table 1. Similarly, the cut-off point was set at > 118 BACT/mL with
optimal sensitivity (84.2%) and speciﬁcity (85.7%) for differentiating
those with growth  104 CFU/mL or not (Table 2). Along with the
best cut-off obtained from ROC curves, the performance of Sysmex
UF1000i urine bacterial count was examined for a range of cut-offs
at  103 CFU/mL,  104 CFU/mL, and  105 CFU/mL in urine culture
(Tables 1e3).Table 2
Diagnostic performance of Sysmex UF1000i bacterial count at different cut-off
values versus urine culture in 651 specimens with 513 positive cultures achieving
growth  104 CFU/mL.
BACT/mL
481.9 250.5 117.6 52
Sensitivity (%) 69.76 76.68 84.19 91.11
Speciﬁcity (%) 95.00 90.71 85.71 67.14
BACT/mL ¼ bacteria count.
Table 3
Diagnostic performance of Sysmex UF1000i bacterial count at different cut-off
values versus urine culture in 651 specimens with 408 positive cultures achieving
growth  105 CFU/mL.
BACT/mL
723.7 357.1 298.3 106.1
Sensitivity (%) 79.70 85.89 87.13 95.79
Speciﬁcity (%) 92.15 88.43 85.12 70.25
BACT/mL ¼ bacteria count.
0
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Figure 1. ROC curve for Sysmex UF1000i BACT/mL, leukocyte esterase, WBC count, and
nitrite of 651 specimens with 404 positive samples (bacterial growth  105 CFU/mL in
urine culture). BACT/mL ¼ bacteria count; ROC ¼ receiver operating characteristic;
WBC ¼ white blood cell.
Table 1
Diagnostic performance of Sysmex UF1000i bacterial count at different cut-off
values versus urine culture in 651 specimens with 561 positive cultures achieving
growth  103 CFU/mL.
BACT/mL
481.9 250.5 117.6 50.4
Sensitivity (%) 64.21 70.86 77.88 86.51
Speciﬁcity (%) 96.67 92.22 85.56 68.89
BACT/mL ¼ bacteria count.3.3. Comparison of ROC
The ROC curve analysis used to compare the predictive ability of
urine BACT/mL, pyuria (WBC count/HPF), nitrite (classiﬁed as
negative, þ, þþ, and þþþ), and leukocyte esterase (classiﬁed as
negative,þ,þþ, andþþþ) is shown in Figure 1. The area under the
ROC curve (AUC) for BACT/mL is 0.944 [95% conﬁdence interval
(CI) ¼ 0.923e0.960], which is higher than that for positive leuko-
cyte esterase (0.716; 95% CI ¼ 0.680e0.751), nitrite (0.701; 95%
CI ¼ 0.664e0.736), and pyuria (0.678; 95% CI ¼ 0.640e0.714). In
pairwise comparison of ROC curves, differences of AUC comparing
bacterial count to leukocyte esterase, pyuria, and nitrite, all reached
statistically signiﬁcance (p < 0.0001). Difference of AUC between
leukocyte esterase and pyuria is also signiﬁcant (p ¼ 0.04); whilethere is no signiﬁcant difference for nitrite compared with leuko-
cyte esterase (p ¼ 0.50) and pyuria (p ¼ 0.35).
Among the four parameters, we found that BACT/mL > 357 bears
the highest odds for signiﬁcant bacteriuria [odds ratio (OR)¼ 40.60,
95% CI¼ 25.49e64.66]. The following is positive nitrite (OR¼ 28.21,
95% CI: 12.25e64.95), positive leukocyte esterase (OR ¼ 6.68, 95%
CI ¼ 4.45e10.01), and the least was pyuria (OR ¼ 3.05, 95%
CI ¼ 2.19e4.24).4. Discussion
We demonstrated that Sysmex UF1000i is an excellent tool to
rapidly diagnose UTI with decent sensitivity and speciﬁcity for
urine culture in women with uUTI (Tables 1e3). Bacterial count
obtained from Sysmex UF1000i outperformed pyuria, leukocyte
esterase, and nitrite for positive culture ( 105 CFU/mL) at all cut-
off points (Figure 1). Our results showed that bacterial counts had
the highest OR (OR ¼ 40.40, 95% CI ¼ 25.49e64.66) and diagnostic
performance (AUC ¼ 0.944, 95% CI ¼ 25.49e64.67 in ROC analysis)
among other parameters. When culture-positive urine samples
were used to compare chemical and sediment exams, bacterial
count exhibited the highest diagnostic performance whether under
microscopic exam3 or automated ﬂow cytometry.6 In the recent
meta-analysis for ﬂow cytometry, the pooled sensitivities and AUC
of ROC curves of bacteria were higher than those ofWBCs (bacteria:
AUC¼ 0.93, sensitivity¼ 92%,WBC: AUC¼ 0.87, sensitivity¼ 87%).6
These results indicated that clinicians could utilize bacteriuria as a
rapid screening tool for UTI in the preanalytical phase of urine
culture. From our results, we proved that bacterial count using the
results from urine ﬂow cytometry is superior to leukocyte, nitrite,
and leukocyte esterase.
Currently, the studies regarding urine ﬂow cytometry are trying
to prove its ability to detect UTI and decrease the need of urine
culture. The urine ﬂow cytometry can not only tell us the infor-
mation of sediments, but also the morphology of bacteria. The aim
of the ﬂow cytometry is to rapidly screen the urine specimen with
C.-C. Yang et al. / Urological Science 27 (2016) 135e139138regard to the possibility of UTI and identify whether the bacteria in
the specimen is gram negative rods or gram positive cocci.13,14
Based on the traditional deﬁnition and well-accepted criteria
used in Taiwan, we assumed a cut-off of 105 CFU/mL as signiﬁcant
bacterial growth in urine culture. Using bacterial growth of 
105 CFU/mL in urine culture, we obtained the optimal cut-off of >
357 BACT/mL with optimal sensitivity and speciﬁcity. However,
various thresholds have been used to diagnose UTI. No ﬁxed bac-
terial count could be applied to different UTIs to indicate signiﬁcant
bacteriuria.15 The bacterial growth ranges from a usual cut-off, 
103 CFU/mL16, deﬁned in the European Association of Urology
guideline of urological infections, to a value as low as  102 CFU/
mL15,17 for uUTI in women with E. coli infection. E. coli, as the most
common cause of UTI, can highly predict bladder bacteriuria at
102 CFU/mL in voidedmidstream urine for symptomatic women. To
accommodate various cut-offs used globally and obtain the best
sensitivity and speciﬁcity at different degrees of bacterial growth,
we also evaluated results at different counts of bacterial growth.
If 103 CFU/mL or 104 CFU/mL is to be used, then > 117.6 BACT/mL
would be the optimal cut-off point (Tables 1e2).
Various cut-off points of bacterial count have been reported in
UTI screening. When urine cultures growing at  105 CFU/mL were
used as a reference, the bacterial count of 106 BACT/mL resulted in a
sensitivity of 95.8% and speciﬁcity of 70.3% (Table 3), which was
similar to the results from De Rosa et al12 who used a bacterial
count of 100/mL as the cut-off point (sensitivity ¼ 96.5%,
speciﬁcity ¼ 86.7%). Giesen et al18 reported the optimum cut-off of
bacterial count at 288.9/mL with a sensitivity of 89% and speciﬁcity
of 79%. If the bacterial count of 298/mL was used as a reference, the
sensitivity was 87.1% and speciﬁcity was 85.1% (Table 3). However,
we found that the optimal cut-off of bacterial count was 357/mL and
resulted in a sensitivity of 85.9% and speciﬁcity of 88.4% (Table 3).
The higher cut-off point, compared with other studies,10,12,18,19
could be attributed to different laboratories, patient populations,
and the type of specimens.12 Recent meta-analysis reviewed the
recent studies to determine the capabilities of Sysmex UF1000i to
detect bacteriuria in UTI screening.6 The pooled sensitivities were
87% and speciﬁcities were 60% for bacteriuria. The AUCwas 0.93 for
bacteriuria. However, many studies included urine samples
without suspected UTI, and they also did not report the contami-
nation rate of urine samples.
A large portion of urine cultures showed mixed growth (n ¼ 467,
27.8%). The relatively high percentage of mixed growth was possibly
becausewe enrolled female patients only, instead of both genders as
in the other studies. In the studies conducted among laboratories in
the USA by the College of American Pathologists, they showed that
the overall contamination rate of urine cultures was 15.0%.20 The
average contamination rate was 0.8% in the top 10% of institutions,
while it was 41.7% in the bottom 10% of institutions.20 The median
institution had a contamination rate of 18.1%.20 The lower percent-
age of samples from female patients, the lower contamination rate
was observed.21 The median contamination rates by sex were 7.4%
for male patients and 17.3% for female patients.20,21 Anatomically,
the length of the urethra and its proximity to the vagina and anus
make it easy for colonizing bacteria to travel to the urinary bladder
inwomen, compared to men. However, it could be also attributed to
samples collected from outpatients.
A total of 90 samples (5.4%) were negative in urine culture. Our
culture-negative rate is much lower than previous studies. Culture-
negative results were up to 97.7% according to the study by Kayalp
et al.3 This could be due to low recruitment thresholds, including
those from screening, prehospitalization, or presurgery testing.
Without specifying the patients' clinical status, Kadkhoda et al11
reported only 27.3% grew signiﬁcant pathogens among 1874
midstream urine samples, while 68.6% showed no growth ornonsigniﬁcant growth. Even in 622 catheterized urine culture
samples, only 34.2% had signiﬁcant bacterial growth. The category
of no growth/nonsigniﬁcant growth, deﬁned by Kadkhoda et al,11
included the deﬁnition of mixed growth as used in our study.
Nevertheless, both studies showed low culture-positive rates, with
high culture-negative and mixed growth rates. When applied to
clinical scenarios, only positive culture results with signiﬁcant
bacterial growth shed light on diagnosing and treating UTIs.
When the bacterial count of > 357 BACT/mL was set to test the
sensitivity and speciﬁcity for urine cultures growing at  105 CFU/
mL for all eligible urine samples, a total of 1168, including mixed
growth (n ¼ 467), growth of fungus (n ¼ 8), lactobacillus (n ¼ 33),
G. vaginalis (n ¼ 8), no growth (n ¼ 90), and various degrees of
growth of positive cultures (n ¼ 561), it showed the results of 86%
and 78.3%, respectively.
By excluding those specimens with the bacterial count of < 357
BACT/mL, we may decrease the urine culture rate by 36.9% and miss
14.0% of true UTIs. When we applied > 106 BACT/mL as the
screening cut-off, the urine culture rate decreased by 27.1%, and
only missed 4.9% of true UTIs. When the higher threshold of < 357
BACT/mL was used, we lowered the need of overtreatment and
unnecessary urine cultures substantially, but paid a higher price of
undetected positive urine cultures. If a lower threshold, < 106
BACT/mL was implemented, we not only signiﬁcantly reduced the
cost for urine cultures, but also treated 95.1% of patients with true
UTIs. To balance the pros and cons, clinicians could apply their own
cut-offs to reach best treatment outcomes in clinical practices. The
outstanding results may strongly inﬂuence clinicians on prescrib-
ing antibiotics for uUTI at outpatient clinics.
In Taiwan, routine urinalysis costs $75 NTD ($2.5 USD), while
urine culture costs $200 NTD ($6.7 USD) under the National In-
surance Health System. In our hospital, a urine routine, analyzed by
urine ﬂow cytometry and another chemistry analyzer, costs $75
NTD. No extra charge is needed to apply urine ﬂow cytometry.
Therefore, the cost of urine culture is almost triple the price of urine
routine. Urine culture is relatively expensive, labor-intensive, time-
consuming, and prone to give false-negative and false-positive re-
sults, whereas Sysmex UF1000i provides cost-effective screening
within 1 minute after urine sampling (100 samples/h). We priori-
tize “rapid diagnosis” in outpatient clinics, followed by the pre-
scription of appropriate empirical antibiotics for the patients with
UTI. In busy outpatient clinics, this means a real-time reporting that
could reduce the blind initiation of antibiotics, and thus prevent
unnecessary expenditure and drug treatment.
Conducting a retrospective review study, we were unable to
ensure the quality of urine collection at outpatient clinics. As well
as spot midstream urine collection, many methods have been
advocated to reduce contamination rate. However, different
methodologies used in midstream urine collection did not yield
signiﬁcant differences in contamination rates.4 Some preliminary
results showed that Sysmex UF1000i may be able to discriminate
Gram-negative and Gram-positive bacteria.12,13 A prospective
study to give precise instructions for midstream urine collection,
as well as follow clinical outcomes of speciﬁc antibiotic use,
based on the timely result provided by Sysmex UF1000i, is
mandated.
5. Conclusions
Laser ﬂow cytometry (Sysmex UF1000i) may be an effective
screening tool with high sensitivity and speciﬁcity for symptomatic
UTI by measuring bacterial count. In clinical implications, timely
results of Sysmex UF1000i provided reliable clues predicting as to
whether the patients had urinary infections in the preanalytical
phase of urine culture.
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